DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
203	22q11.2欠失症候群	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04639960 (ClinicalTrials.gov)	September 29, 2017	3/11/2020	Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome	Effects of Modulation of the Dopaminergic System Using Risperidone on Memory and Executive Processes in Individuals With 22q11.2 Deletion Syndrome	22q11.2 Deletion Syndrome	Drug: Risperdal;Drug: Placebo	University of Geneva, Switzerland	NULL	Recruiting	11 Years	25 Years	All	30	N/A	Switzerland

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

September 29, 2017

3/11/2020

Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome

Effects of Modulation of the Dopaminergic System Using Risperidone on Memory and Executive Processes in Individuals With 22q11.2 Deletion Syndrome

22q11.2 Deletion Syndrome

Drug: Risperdal;Drug: Placebo

University of Geneva, Switzerland

NULL

Recruiting

11 Years

25 Years

All

N/A

Switzerland